Compounds > pd 158780

pd 158780 and pd 153035

pd 158780 has been researched along with pd 153035 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridges, AJ; Cody, DR; Denny, WA; Fry, DW; McMichael, A; Palmer, BD; Rewcastle, GW; Thompson, AM; Zhou, H1
Bridges, AJ; Fry, DW; McMichael, A; Sercel, AD; Showalter, HD; Zhou, H1
Dai, JR; Deretey, E; Foster, JE; Ng, W; Pasternak, A; Redden, PR; Reid, N; Slon-Usakiewicz, JJ; Toledo-Sherman, L1
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Albarran, MI; Bischoff, JR; Corrionero, A; Fominaya, J; Mateos, G; Oyarzabal, J; Palacios, I; Pastor, J; Rabal, O; Reymundo, I; Salgado, A; Urbano-Cuadrado, M; Zarich, N1

Other Studies

5 other study(ies) available for pd 158780 and pd 153035

ArticleYear
Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor.
    Journal of medicinal chemistry, 1996, Apr-26, Volume: 39, Issue:9

    Topics: ErbB Receptors; Humans; Isomerism; Magnetic Resonance Spectroscopy; Phosphorylation; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured

1996
Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]ĭndoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase.
    Journal of medicinal chemistry, 1999, Dec-30, Volume: 42, Issue:26

    Topics: Amino Acid Sequence; Enzyme Inhibitors; ErbB Receptors; Humans; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Protein-Tyrosine Kinases; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured

1999
Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA.
    Journal of medicinal chemistry, 2004, Oct-07, Volume: 47, Issue:21

    Topics: Chromatography, Affinity; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Ligands; Mass Spectrometry; Models, Molecular; Receptor, EphB2

2004
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.
    Journal of medicinal chemistry, 2010, Sep-23, Volume: 53, Issue:18

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Databases, Factual; Drug Screening Assays, Antitumor; Humans; Intracellular Signaling Peptides and Proteins; Models, Molecular; Protein Conformation; Protein Serine-Threonine Kinases; Quantitative Structure-Activity Relationship

2010